CytomX Therapeutics, Inc. Contracts & Agreements

90 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No.1 to the Collaboration and License Agreement effective as of June 28, 2024 by and between CytomX Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2024
Amendment No. 4 to the Collaboration and License Agreement, dated as of March 28, 2024, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2024
Transition Agreement effective as of August 22, 2023 by and between CytomX Therapeutics, Inc., and AbbVie Global Enterprises Ltd
Transition Agreements
CytomX Therapeutics, Inc.
2023
Employment Offer Letter Agreement between CytomX Therapeutics, Inc. and Jeffrey Landau dated as of March 31, 2021
Employment Agreements
CytomX Therapeutics, Inc.
2023
Form of Amended and Restated Severance and Change of Control Agreement by and between CytomX Therapeutics, Inc. and each of its executive officers other than Sean A. McCarthy
Change of Control Agreements
CytomX Therapeutics, Inc.
2023
Amendment No. 3 to the Collaboration and License Agreement, dated as of May 18, 2023, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2023
Form of Pre-Funded Warrant
Warrant Agreements
CytomX Therapeutics, Inc.
2023
Form of Tranche Warrant
Warrant Agreements
CytomX Therapeutics, Inc.
2023
Unit Purchase Agreement by and among the Company and the Purchasers, dated June 29, 2023
Purchase Agreements
CytomX Therapeutics, Inc.
2023
Consulting Agreement effective as of October 1, 2022, by and between CytomX Therapeutics, Inc. and Carlos Campoy
Consulting Agreements
CytomX Therapeutics, Inc.
2022
Consulting Agreement effective as of September 13, 2022, by and between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D
Consulting Agreements
CytomX Therapeutics, Inc.
2022
Separation Agreement effective as of September 30, 2022, by and between CytomX Therapeutics, Inc. and Carlos Campoy
Separation Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2022
Separation Agreement effective as of September 30, 2022, by and between CytomX Therapeutics, Inc. and Alison Hannah, M.D
Separation Agreements
CytomX Therapeutics, Inc.
2022
Amendment No 3 to Collaboration and License Agreement, dated May 23, 2014, by and between the Company and Bristol Myers Squibb Company, effective as of October 11, 2022
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2022
Separation Agreement effective as of September 12, 2022, by and between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D
Separation Agreements
CytomX Therapeutics, Inc.
2022
Amendment No. 2 to the Collaboration and License Agreement, dated as of October 27, 2021, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2022
Form of 2015 Plan Restricted Share Unit Award Grant Notice and Agreement
Share Agreements
CytomX Therapeutics, Inc.
2022
Consulting Agreement, effective as of April 1, 2021, by and between CytomX Therapeutics, Inc. and Dr. Charles Fuchs
Consulting Agreements
CytomX Therapeutics, Inc.
2021
Amendment No 2 to Collaboration and License Agreement, as amended, dated March 17, 2017, by and between the Company and Bristol Myers Squibb, effective as of February 22, 2021
Collaboration Agreements
CytomX Therapeutics, Inc.
2021
Retirement Agreement by and between CytomX Therapeutics, Inc and Dr. W. Michael Kavanaugh, dated as of December 1, 2020
Retirement Agreements
CytomX Therapeutics, Inc.
2021
Consulting Agreement effective as of December 14, 2020, by and between CytomX Therapeutics, Inc and Dr. W. Michael Kavanaugh
Consulting Agreements
CytomX Therapeutics, Inc.
2021
Underwriting Agreement, dated as of January 20, 2021, among CytomX Therapeutics, Inc. and J.P Morgan securities LLC, Cowen and Company, LLC and Piper Sandler & Co., as...
Underwriting Agreements
CytomX Therapeutics, Inc.
2021
Research Collaboration, Option and License Agreement dated as of May 30, 2013, by and between CytomX Therapeutics, Inc. and Pfizer, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2020
Amendment No. 1 to the Collaboration and License Agreement, dated as of September 29, 2020, by and between CytomX Therapeutics, Inc. and Amgen, Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2020
Collaboration and License Agreement dated as of May 23, 2014, by and between CytomX Therapeutics, Inc. and Bristol-Myers Squibb Company
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NJ
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
CytomX Therapeutics, Inc.
Biotechnology
2020
Collaboration and License Agreement dated as of March 23, 2020, by and between CytomX Therapeutics, Inc. and Astellas Pharma Inc
Collaboration Agreements
CytomX Therapeutics, Inc.
2020
Employment Offer Letter Agreement between CytomX Therapeutics, Inc. and Carlos Campoy dated as of March 9, 2020
Employment Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2020
Severance and Change of Control Agreement dated March 23, 2020, by and between CytomX Therapeutics, Inc. and Carlos Campoy
Change of Control Agreements
CytomX Therapeutics, Inc.
Biotechnology
2020
Severance and Change of Control Agreement effective as of February 3, 2020, by and between CytomX Therapeutics, Inc. and Alison Hannah, M.D
Change of Control Agreements
CytomX Therapeutics, Inc.
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
CytomX Therapeutics, Inc.
Biotechnology
2020
Open Market Sale Agreement, dated as of February 27, 2020, by and between CytomX Therapeutics, Inc. and Jefferies LLC
CytomX Therapeutics, Inc.
2020
Form of Stock Option Agreement under the 2019 Plan
Stock Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2019
Severance and Change of Control Agreement effective as of October 14, 2019, by and between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D
Change of Control Agreements
CytomX Therapeutics, Inc.
2019
Employment Offer Letter Agreement between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D. dated as of September 23, 2019
Employment Agreements
CytomX Therapeutics, Inc.
Biotechnology
2019
Separation Agreement effective as of September 5, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D
Separation Agreements
CytomX Therapeutics, Inc.
2019
Consulting Agreement effective as of August 19, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D
Consulting Agreements
CytomX Therapeutics, Inc.
2019
2019 Employment Inducement Incentive Plan adopted on September 18, 2019 (2019 Plan)
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2019
Amended and Restated Discovery Collaboration and License Agreement, dated as of June 28, 2019, by and between CytomX Therapeutics, Inc., and AbbVie Ireland Unlimited Company
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2019
Amended and Restated Severance and Change of Control Agreement dated February 27, 2019, by and between CytomX Therapeutics, Inc. and Sean McCarthy. D. Phil
Change of Control Agreements
CytomX Therapeutics, Inc.
2019
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Lloyd Rowland
Change of Control Agreements
CytomX Therapeutics, Inc.
Biotechnology
2019
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D
Change of Control Agreements
CytomX Therapeutics, Inc.
2019
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Michael Kavanaugh, M.D
Change of Control Agreements
CytomX Therapeutics, Inc.
2019
Amended and Restated Severance and Change of Control Agreement dated March 25, 2019, by and between CytomX Therapeutics, Inc. and Debanjan Ray
Change of Control Agreements
CytomX Therapeutics, Inc.
Biotechnology
2019
Amendment No.3 to Exclusive License Agreement effective as of April 2, 2019, by and between CytomX Therapeutics, Inc. and The Regents of the University of California
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2019
Consulting Agreement effective as of May 15, 2019, by and between CytomX Therapeutics, Inc. and Debanjan Ray
Consulting Agreements
CytomX Therapeutics, Inc.
2019
Consulting Agreement between CytomX Therapeutics, Inc and Dr. Hoyoung Huh, effective as of December 30, 2018
Consulting Agreements
CytomX Therapeutics, Inc.
2019
License Agreement by and between CytomX Therapeutics, Inc. and ImmunoGen Inc., dated as of February 12,2016
License Agreements
CytomX Therapeutics, Inc.
2018
First Amendment to the CD71 Co-Development and License Agreement by and between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company, dated as of October 5, 2016
License Agreements
CytomX Therapeutics, Inc.
2018
Second Amendment to the CD71 Co-Development and License Agreement by and between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company, dated as of March 31, 2017
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Third Amendment to the CD71 Co-Development and License Agreement by and between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company, dated as of January 3, 2018
License Agreements
CytomX Therapeutics, Inc.
2018
Second Amendment to the Research Collaboration Agreement by and between CytomX Therapeutics, Inc. and ImmunoGen Inc., dated as of February 12,2016
Collaboration Agreements
CytomX Therapeutics, Inc.
2018
Third Amendment to the Research Collaboration Agreement by and between CytomX Therapeutics, Inc. and ImmunoGen Inc., dated as of March 3, 2017
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Severance and Change of Control Agreement, by and between CytomX Therapeutics, Inc. and Lloyd Rowland, dated as of May 16, 2018
Change of Control Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Underwriting Agreement, dated as of July 12, 2018, among CytomX Therapeutics, Inc. and Goldman Sachs & Co. LLC and Citigroup Global Markets Inc., as representatives of the...
Underwriting Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Registration Rights Agreement dated as of September 29, 2017 by and between CytomX Therapeutics, Inc. and Amgen, Inc
Registration Rights Agreements
CytomX Therapeutics, Inc.
2017
Collaboration and License Agreement by and between CytomX Therapeutics, Inc. and Amgen, Inc. dated as of September 29, 2017
Collaboration Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2017
SEPARATION AGREEMENT
Separation Agreements
CytomX Therapeutics, Inc.
2017
[Signatures appear on the following page.]
CytomX Therapeutics, Inc.
Biotechnology
2017
AMENDMENT NUMER 1 TO EXTEND COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
CytomX Therapeutics, Inc.
2017
[Signatures appear on the following page.]
CytomX Therapeutics, Inc.
2017
[Signatures appear on the following page.]
CytomX Therapeutics, Inc.
Biotechnology
2017
[Signatures appear on the following page.]
CytomX Therapeutics, Inc.
2017
[Signatures appear on the following page.]
CytomX Therapeutics, Inc.
Biotechnology
2016
FIRST AMENDMENT TO SEVERANCE AND CHANGE OF CONTROL AGREEMENT
Change of Control Agreements
CytomX Therapeutics, Inc.
2016
THE COVE AT OYSTER POINT LEASE
Lease Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2015
CytomX Therapeutics, Inc. 2015 Equity Incentive Plan Option Award Notice
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
2015
CytomX Therapeutics, Inc. 2015 Equity Incentive Plan Early Exercise Option Award Notice
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2015
CYTOMX THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN Adopted by Board: September 17, 2015 Approved by Stockholders: October 2, 2015 Termination Date: September 17, 2025
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
2015
CYTOMX THERAPEUTICS, INC. (aDelaware corporation) Shares of CommonStock UNDERWRITING AGREEMENT
Underwriting Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2015
CYTOMX THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN Adopted by Board: September 17, 2015 Termination Date: September 17, 2025
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
2015
CYTOMX THERAPEUTICS, INC. EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
CytomX Therapeutics, Inc.
2015
SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS
Separation Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2015
SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS
Separation Agreements
CytomX Therapeutics, Inc.
Biotechnology
2015
2010 STOCK INCENTIVE PLAN CYTOMX THERAPEUTICS, INC. a Delaware corporation September 21, 2010 2010 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
2015
AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
CytomX Therapeutics, Inc.
2015
WARRANT TO PURCHASE PREFERRED STOCK
Warrant Agreements
CytomX Therapeutics, Inc.
2015
CYTOMX THERAPEUTICS, INC. 2011 STOCK INCENTIVE PLAN PREFACE
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
2015
CYTOMX THERAPEUTICS, INC. 2011 STOCK INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2015
SEPARATION AGREEMENT AND GENERAL RELEASE OF CLAIMS
Separation Agreements
CytomX Therapeutics, Inc.
2015
CYTOMX THERAPEUTICS, INC. STOCK OPTION AGREEMENT (2010 Stock Incentive Plan)
Bonus & Incentive Agreements
CytomX Therapeutics, Inc.
2015
460 WARD DRIVE, SUITE E1 SANTA BARBARA, CA 93111 TEL ###-###-#### FAX ###-###-#### WWW.CYTOMX.COM Revised December 15, 2010
CytomX Therapeutics, Inc.
Biotechnology
CA
2015
AMENDMENT NO. 1 TO MASTER LOAN AND SECURITY AGREEMENT NO. CYTOX
Loan Agreements
CytomX Therapeutics, Inc.
Biotechnology
2015
ATEL VENTURES, INC. MASTER LOAN AND SECURITY AGREEMENT NO. CYTOX Dated as of May 31, 2012
Loan Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2015
MASTER LOAN AND SECURITY AGREEMENT No. CYTOY Dated as ofDecember 20, 2013
Loan Agreements
CytomX Therapeutics, Inc.
Biotechnology
CA
2015
LEASE AGREEMENT
Lease Agreements
CytomX Therapeutics, Inc.
2015
RESEARCH COLLABORATION, OPTION AND LICENSE AGREEMENT BY AND BETWEEN PFIZERINC. AND CYTOMX THERAPEUTICS, INC. MAY 30, 2013
Collaboration Agreements
CytomX Therapeutics, Inc.
2015
COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
CytomX Therapeutics, Inc.
2015
RESEARCH COLLABORATION AGREEMENT BETWEEN CYTOMXTHERAPEUTICS, INC. AND IMMUNOGEN, INC. JANUARY 8, 2014
Collaboration Agreements
CytomX Therapeutics, Inc.
2015
INDEMNIFICATION AGREEMENT
Indemnification Agreements
CytomX Therapeutics, Inc.
Biotechnology
DE
2015